FRACTYL HEALTH, INC. GUTS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
2/9
Piotroski F — financial health
-16.47
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $0 | -$141.0M | — | -$90.9M | $9.5M |
| 2024 | $93,000 | -$68.7M | $43,000 | -$67.3M | $28.4M |
| 2023 | $120,000 | -$77.1M | $43,000 | -$43.2M | -$325.1M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -16.47 (distress)
- Working capital / assets 0.57
- Retained earnings / assets -4.582
- EBIT / assets -0.797
- Equity / liabilities 0.084
Source: SEC EDGAR filings · CIK 0001572616 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.